|
YWHAG expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.12029999721486E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.237460E-04 |
| Normal-vs-Stage2 |
1.483760E-02 |
| Normal-vs-Stage3 |
9.152200E-04 |
| Normal-vs-Stage4 |
2.270400E-02 |
| Stage1-vs-Stage2 |
6.165200E-01 |
| Stage1-vs-Stage3 |
5.585500E-02 |
| Stage1-vs-Stage4 |
1.061420E-01 |
| Stage2-vs-Stage3 |
3.567200E-01 |
| Stage2-vs-Stage4 |
1.729050E-01 |
| Stage3-vs-Stage4 |
3.257200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.67530000269889E-08 |
| Normal-vs-AfricanAmerican |
2.456000E-03 |
| Normal-vs-Asian |
1.310840E-01 |
| Caucasian-vs-AfricanAmerican |
2.528400E-01 |
| Caucasian-vs-Asian |
3.715800E-01 |
| AfricanAmerican-vs-Asian |
2.821400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.20759999952836E-07 |
| Normal-vs-Female |
1.93650000002155E-06 |
| Male-vs-Female |
6.754300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.460140E-02 |
| Normal-vs-Extreme_Weight |
1.013360E-04 |
| Normal-vs-Obese |
4.1821000000053E-05 |
| Normal-vs-Extreme_Obese |
1.516390E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.229400E-01 |
| Normal_Weight-vs-Obese |
6.321200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.199600E-01 |
| Extreme_Weight-vs-Obese |
6.111600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.493000E-01 |
| Obese-vs-Extreme_Obese |
6.528800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.603060E-03 |
| Normal-vs-Age(41-60Yrs) |
5.07570000474189E-08 |
| Normal-vs-Age(61-80Yrs) |
1.241710E-04 |
| Normal-vs-Age(81-100Yrs) |
3.641000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.256300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.171500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.962410E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.944300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.360990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.651600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.07029999973918E-07 |
| Normal-VS-Type2 PRCC |
9.044500E-04 |
| Normal-VS-KIRP CIMP |
1.035350E-03 |
| Normal-VS-Unclassified PRCC |
1.743190E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.382400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.044200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.158800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.27419999999645E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
9.579000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.417500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.655600E-02 |
| Normal-vs-N1 |
5.90269999999338E-05 |
| Normal-vs-N2 |
2.249600E-01 |
| N0-vs-N1 |
1.298480E-03 |
| N0-vs-N2 |
3.116200E-01 |
| N1-vs-N2 |
4.719600E-01 |
|
|
